TALTZ (IXEKIZUMAB) — FDA Approval BLA125521 (ELI LILLY AND CO)
TALTZ (IXEKIZUMAB) — FDA Approval BLA125521 (ELI LILLY AND CO) is one of 9,000 drug approvals in the DrugApprovals dataset. Key details — Brand name: TALTZ; Active ingredients: IXEKIZUMAB; Application number: BLA125521.
| Brand name | TALTZ |
|---|---|
| Active ingredients | IXEKIZUMAB |
| Application number | BLA125521 |
| Sponsor | ELI LILLY AND CO |
| Dosage form | INJECTABLE |
| Route | INJECTION |
| Marketing status | Prescription |
| Products in application | 1 |
| First approval date | 20160322 |
| Source | openFDA Drugs@FDA |
$1499/mo
Try DrugApprovals →